Viewing Study NCT01504256


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-02-26 @ 4:18 PM
Study NCT ID: NCT01504256
Status: COMPLETED
Last Update Posted: 2018-01-23
First Post: 2012-01-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas
Sponsor: AIO-Studien-gGmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastric Adenocarcinoma With Peritoneal Carcinomatosis View
None Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis View
None Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adenocarcinoma View
None Esophagogastric Junction View
None Peritoneal Carcinomatosis View
None Catumaxomab View
None AIO-STO-0110 View